Membership Online Payment

Is Available Now



Dr. Chang Shu got his medical degree at Hunan Medical College in 1989 and his Ph.D. at Beijing Medical College in 2000. In the Ph.D. program, he learned from Dr. Zhonghao Wang who is an academician of the Chinese Academy of Sciences. After getting Ph.D., he was selected by Beijing Medical College to study abroad at Stanford University and performed his post-doctoral research in Dr. C.K Zarins’ lab, who was the president of the Society for Vascular Surgery. He returned to China in 2002 and was named the director of the Department of Vascular Surgery at Second Xiangya Hospital.

He started his 5-day visit to Egypt on Tuesday, 26 December 2023, discussing bilateral ties between the old civilizations of both countries and common vascular surgery concerns with the Egyptian Vascular and Endovascular Society secretariat; Dr. Sherif Elkerdawi. During a 3-hour meeting, both doctors reached a statement of collaboration between the Egyptian Vascular and Endovascular Society and the National Society of Vascular Surgery of China.

Wednesday Morning, Dr. Chang Shu, Dr. Sherif Elkerdawi, and Dr. Mohamed Hosni Eldesokki; the head of the Egyptian Vascular and Endovascular Society visited the Cardiothoracic Surgery and Vascular Surgery Center, at Mansoura University.

During his visit to Mansoura, he performed an advanced aortic intervention procedure for one patient with Aortic Dissection. The procedure was Insitu Needle Fenestration for Left Subclavian Artery with TEVAR using new gutter-free C-skirt stent graft. It was done for the first time in Egypt by the investigator of the technique. Thursday Morning, Dr. Chang Shu and Dr. Mohamed Hosni Eldesokki; visited Gamal Abdelnasser Hospital, Alexandria. They did another advanced aortic intervention for a patient suffering from Aortic dissection through insitu needle fenestration TEVAR. We were proud to welcome Dr. Chang Shu at the historical Princess Fatma palace. Dr. Chang Shu summarized his practice during the last decade treating aortic arch pathologies such as aortic dissections and aneurysms which is challenging for vascular surgeons. He confirmed that the chimney (C-TEVAR), on-the-table fenestration (F-TEVAR), and in-situ fenestration (I-TEVAR) are TEVAR-assistive techniques, that could be accomplished with readily available devices. And, concluded that Total endovascular treatments for patients with aortic arch pathologies are challenging because of the diverse vascular anatomies of both the aorta and the aortic branches. The signing ceremony was successfully done between Dr. Mohamed Hosni Eldessoki (Egypt) and Dr. Chang Shu (China). They signed a Goodwill Agreement between the Egyptian Vascular and Endovascular Society and the National Vascular Society of China that ensures that each continent will continue to exchange scientific data to improve care for all patients!

Scroll to Top